+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Stimulants for depression: On the up and up?



Stimulants for depression: On the up and up?



Australian and New Zealand Journal of Psychiatry 50(3): 203-207



The use of traditional psychostimulants (methylphenidate and dexamphetamine) and stimulant-like drugs (modafinil and armodafinil) for the treatment of depression is a growing concern given the lack of research evidence supporting their effectiveness. The current article describes the role of stimulants in treating depression--specifically their risks and benefits and their potential use alongside antidepressants. Clinically, the rapid amelioration of depressive symptoms with traditional psychostimulants is often dramatic but short-lived, and this suggests that they likely operate via different mechanisms to conventional antidepressants. More importantly, there is little evidence from randomised controlled trials supporting their efficacy in treating depression, although modafinil has been shown to be effective in reducing prominent depressive symptoms, such as fatigue. Research is urgently required to clarify psychostimulants' mechanisms of action and to evaluate their long-term benefits and risks in the treatment of major and bipolar depression. Ultimately, specificity of action needs to be determined to inform the sophisticated clinical use of psychostimulants in the management of depression. Until then they should only be prescribed if absolutely necessary, and even then their prescription should be facilitatory and time limited unless it is for investigational purposes.

(PDF emailed within 0-6 h: $19.90)

Accession: 058905695

Download citation: RISBibTeXText

PMID: 26906078

DOI: 10.1177/0004867416634208


Related references

Depression syndromes; treatment by stimulants. Medicina Contemporanea 75(2): 53-79, 1957

Why do stimulants not work in typical depression?. Australian and New Zealand Journal of Psychiatry 51(1): 20-22, 2016

Stimulants in the treatment of depression: a critical overview. Journal of Clinical Psychiatry 50(7): 241-249, 1989

The role of stimulants in late-life depression. American Journal of Psychiatry 172(6): 505-507, 2015

Use of adjunctive stimulants in adult bipolar depression. International Journal of Neuropsychopharmacology 16(1): 55-68, 2013

Psychomotor stimulants and dopamine agonists in depression. Post, R M And J C Ballenger (Ed ) Frontiers Of Clinical Neuroscience, Vol 1 Neurobiology Of Mood Disorders Xvii+887p Williams And Wilkins: Baltimore, Md , Usa; London, England Illus 619-628, 1984

The comparative action of some stimulants in acute morphine depression. Medical Record and Annals 42(1): 401, 1948

Prevention of alcohol-induced cortical depression with stimulants and tertiary amines. Quarterly Journal of Studies on Alcohol 28(1): 1-10, 1967

The state of depression as a model for short experimental tests of stimulants and thymoleptics. Wiener Zeitschrift für Nervenheilkunde und Deren Grenzgebiete 24(1): 122-127, 1966

Depression and sexual dysfunction among HIV-positive and HIV-negative men who have sex with men: mediation by use of antidepressants and recreational stimulants. Archives of Sexual Behavior 44(2): 399-409, 2015

Psycho-stimulants for depression a systematic review of evidence from randomised controlled trials. 2013

A comparison of the action of amphetamine with other central nervous system stimulants in morphine respiratory depression. Proc And Trans Texas Acad Sci 28: 95, 1945

A comparison of amphetamine sulfate with other stimulants of the central nervous system in morphine respiratory depression. Anesthesiology 6: 561-564, 2010

Assessing the roles of stimulants/stimulant-like drugs and dopamine-agonists in the treatment of bipolar depression. Current Psychiatry Reports 15(8): 378, 2013

Central nervous system stimulants as nonspecific antagonists of morphine-induced respiratory depression. Eksperimental'naia i Klinicheskaia Farmakologiia 55(5): 11-15, 1992